Somewhere in an acute trust, a validation team opens a shared list and finds a referral-to-treatment pathway that has gone quiet. The specialty is wrong, a required action was never recorded, and a patient has been waiting longer than anyone realised. Before the Federated Data Platform, that discovery might have depended on a spreadsheet and a lucky catch. Now it depends on a live list that clinicians and managers review together. Rebecca Llewellyn has spent much of her time making that moment ordinary.

Llewellyn is Director of Data Management and Transformation at NHS England, and published programme-board minutes from June 2026 show her chairing the board that governs the platform. She has now been named Digital Transformation Champion of the Year 2026 at the Women in Tech Awards. The recognition arrives while the programme is being judged hard, and the timing suits it. Her work answers the question that has followed the platform since procurement: does it help hospitals run better?

The adoption figures give a first answer. NHS England reports 139 trusts live, 137 of them reporting benefits, and 170 with signed agreements to join. Thirty-five integrated care boards are live. A programme of that reach cannot be run as a technology project. It needs training, business change, benefits tracking and continuing support, which is why the Centre of Excellence matters. Llewellyn's remit covers the translation of policy, governance and platform capability into products that trusts adopt and keep using.

The operational results sit behind that effort. NHS England says 4.69 million referral-to-treatment records have been reviewed and 993,477 people removed from waiting lists after pathway validation. Organisations using the inpatient coordination tools have carried out more than 111,000 additional procedures in theatres compared with the period before. The discharge tracking application OPTICA is associated with lower delay days for long-stay patients. NHS England is careful to say these are before-and-after comparisons that do not establish causation. That candour is part of what makes the evidence usable by sceptical executives.

North West Anglia NHS Foundation Trust offers the clearest illustration. Working with legacy systems and preparing for a new electronic patient record, the trust reviewed more than 11,000 pathways and removed over 3,000 from its patient tracking list. Some 27.5% of reviewed pathways were cleared or corrected. Fragmented spreadsheets gave way to a live operational view. For a patient, that can mean a shorter wait. For a clinician, it means working from the right assumptions.

The wider setting explains why this matters now. Trusts are heading into winter with elective recovery targets, financial constraints and emergency demand all pressing at once. Few have the analytical capacity to build their own intelligence tools, and the service cannot wait for every organisation to do so. A shared operating picture lets a chief operating officer and a clinical director look at the same list and agree on what to do next. That requires leadership that understands both national architecture and the daily reality of a bed management meeting.

Colleagues describe that combination in plain terms. Ayub Bhayat, Chief Data and Analytics Officer, credits her with energy, vision and determination, and says these qualities show in the strength of the teams she leads. Her record supports the description. A national programme in its third year could easily have settled into steady maintenance. Under her direction it has kept moving towards the front line.

Her next project looks beyond the platform. Llewellyn plans to establish a Women in Tech Network for the NHS, giving colleagues a place to connect, mentor and share experience, and creating routes for women entering technology, digital and data careers. The health service has a workforce problem in digital roles as much as in clinical ones, and a visible, supported community is a practical response. Bhayat has offered the network his full backing on behalf of the Data and Analytics senior leadership team.

Scrutiny of the platform will continue, and it should. Privacy, supplier dependence and the credibility of claimed benefits all deserve open testing. Llewellyn's approach of publishing evidence, stating its limits and supporting trusts through adoption gives that scrutiny something firm to examine. The award recognises a leader whose work can be checked against waiting lists, theatre lists and discharge data, and so far the checking favours her.

‍